Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Novo Nordisk
Biotech
Novo ends all cell therapy R&D, lets go of staff
Novo is looking for partners to further develop its cell therapy programs, a spokesperson told Fierce Biotech.
Gabrielle Masson
Oct 10, 2025 3:30pm
Novo inks $4.7B Akero buyout to bag late-phase MASH prospect
Oct 9, 2025 8:21am
Skye's CB1 blocker fails to reduce weight in obesity study
Oct 6, 2025 7:55am
Big pharma cuts and gene therapy woes: Inside Q3's layoffs
Oct 3, 2025 4:30pm
Novo vs. KBP Chapter 2: 'Anomalous' trial results
Oct 2, 2025 3:00am
Novo calls off $598M Heartseed collab, citing 'strategic reviews'
Sep 30, 2025 1:55pm
